Calcium regulators and calcium salts

Biochem/physiol Actions 2,3-Bis(4-hydroxyphenyl)-propionitrile (Diarylprepionitrile, DPN) is an ER&#946-selective agonist IC 50 = 15nM. DPN protects WT and ARKO mice and significantly decreases IL-1&#946 following LPS treatment in young

Biochem/physiol Actions 2,3-Bis(4-hydroxyphenyl)-propionitrile (Diarylprepionitrile, DPN) is an ER&#946-selective agonist IC 50 = 15nM. DPN protects WT and ARKO mice and significantly decreases IL-1&#946 following LPS treatment in young

A-317491 sodium salt hydrate is a potent, selective and non-nucleotide antagonist of P2X 3 and P2X 2/3 receptors , with K i s of 22, 22, 9, and 92 nM for hP2X 3 , rP2X 3 , hP2X 2/3 , and rP2X 2/3 , respectively. A-317491 sodium salt hydrate is

A dual antagonist of TP and EP4 receptors inhibits TxA2-induced platelet aggregation (IC₅₀ = 0.26 &muM) and bronchial smooth muscle contraction impairs PGE2-mediated relaxation of piglet saphenous vein, suppresses serum-induced

A dual antagonist of TP and EP4 receptors inhibits TxA2-induced platelet aggregation (IC₅₀ = 0.26 &muM) and bronchial smooth muscle contraction impairs PGE2-mediated relaxation of piglet saphenous vein, suppresses serum-induced

A dual antagonist of TP and EP4 receptors inhibits TxA2-induced platelet aggregation (IC₅₀ = 0.26 &muM) and bronchial smooth muscle contraction impairs PGE2-mediated relaxation of piglet saphenous vein, suppresses serum-induced

A dual antagonist of TP and EP4 receptors inhibits TxA2-induced platelet aggregation (IC₅₀ = 0.26 &muM) and bronchial smooth muscle contraction impairs PGE2-mediated relaxation of piglet saphenous vein, suppresses serum-induced

A selective FFAR4 antagonist (pIC₅₀s = 7.1 versus &lt 4.6 for human FFAR4 and FFAR1 receptors, respectively) that inhibits intracellular calcium accumulation induced by either linoleic acid or an FFAR4 agonist.

A selective FFAR4 antagonist (pIC₅₀s = 7.1 versus &lt 4.6 for human FFAR4 and FFAR1 receptors, respectively) that inhibits intracellular calcium accumulation induced by either linoleic acid or an FFAR4 agonist.

A selective FFAR4 antagonist (pIC₅₀s = 7.1 versus &lt 4.6 for human FFAR4 and FFAR1 receptors, respectively) that inhibits intracellular calcium accumulation induced by either linoleic acid or an FFAR4 agonist.

A selective FFAR4 antagonist (pIC₅₀s = 7.1 versus &lt 4.6 for human FFAR4 and FFAR1 receptors, respectively) that inhibits intracellular calcium accumulation induced by either linoleic acid or an FFAR4 agonist.

Angiotensin II plays an important role in the regulation of blood pressure and has strong vasoconstrictive effects. It also stimulates the release of aldosterone from the adrenal gland and inhibits adenylate cyclase activity in spontaneously